BNP Paribas Financial Markets’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,738	Closed	-$103K	–	4121
2021 Q2	$103K	Sell	3,738 -10,404	-74%	-$204K	﹤0.01%	3031
2021 Q1	$233K	Buy	14,142 +4,507	+47%	+$103K	﹤0.01%	2965
2020 Q4	$178K	Sell	9,635 -6,454	-40%	-$116K	﹤0.01%	2940
2020 Q3	$219K	Buy	16,089 +11,853	+280%	+$183K	﹤0.01%	2727
2020 Q2	$75.9K	Sell	4,236 -6,486	-60%	-$97.8K	﹤0.01%	2871
2020 Q1	$107K	Buy	10,722 +6,670	+165%	+$54.6K	﹤0.01%	3169
2019 Q4	$33K	Sell	4,052 -671	-14%	-$6.19K	﹤0.01%	3853
2019 Q3	$46.8K	Buy	4,723 +1,431	+43%	+$13.5K	﹤0.01%	3510
2019 Q2	$41.6K	Sell	3,292 -2,892	-47%	-$30.5K	﹤0.01%	3531
2019 Q1	$63K	Buy	+6,184	New	+$47.4K	﹤0.01%	3379

BNP Paribas Financial Markets's TBIO Position: Q3 2021 in Review

BNP Paribas Financial Markets sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 3,738 shares — an estimated $103K sold.

BNP Paribas Financial Markets first reported a position in TBIO in Q1 2019 and held it in 10 quarters. The position peaked at $233K in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

BNP Paribas Financial Markets reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
BNP Paribas Financial Markets sold 3,738 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $103K.
BNP Paribas Financial Markets first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
BNP Paribas Financial Markets's Translate Bio, Inc. Common Stock position peaked at $233K in Q1 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.